{"subnetworks": [{"diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"], "links": [{"source": "ENSG00000023228", "target": "ENSG00000115286", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000136521", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000139180", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000140990", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "type": "directed", "target": "ENSG00000158864", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000164258", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000167792", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000184752", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000065518", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000115286"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000145494"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000167792"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000213619"}, {"source": "ENSG00000115286", "type": "directed", "target": "ENSG00000158864"}, {"source": "ENSG00000115286", "target": "ENSG00000198888", "reverse": "rev-directed"}, {"source": "ENSG00000115286", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000119421", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000128311", "target": "ENSG00000198888"}, {"source": "ENSG00000128609", "target": "ENSG00000183648", "reverse": "rev-directed"}, {"source": "ENSG00000128609", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "target": "ENSG00000147684", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "target": "ENSG00000164258", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "target": "ENSG00000167792", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000131495", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000137806", "type": "directed", "target": "ENSG00000213619"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000140990"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000166136"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000167792"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000184983"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000140990", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000145494", "type": "directed", "target": "ENSG00000158864"}, {"source": "ENSG00000145494", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000147684", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000158864", "target": "ENSG00000167792", "reverse": "rev-directed"}, {"source": "ENSG00000158864", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000158864", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000160194", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000160194", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000164258", "type": "directed", "target": "ENSG00000167792"}, {"source": "ENSG00000164258", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000164258", "type": "directed", "target": "ENSG00000213619"}, {"source": "ENSG00000165264", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000166136", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000167792", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000167792", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000178127", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000184752", "target": "ENSG00000184983", "reverse": "rev-directed"}, {"source": "ENSG00000184752", "type": "directed", "target": "ENSG00000213619", "reverse": "rev-directed"}, {"source": "ENSG00000198695", "type": "directed", "target": "ENSG00000213619"}, {"source": "ENSG00000198786", "type": "directed", "target": "ENSG00000213619"}, {"source": "ENSG00000198888", "type": "directed", "target": "ENSG00000213619"}, {"source": "ENSG00000213619", "type": "directed", "target": "ENSG00000267855", "reverse": "rev-directed"}, {"source": "ENSG00000198886", "type": "manual", "target": "ENSG00000130159"}, {"source": "ENSG00000130159", "type": "manual", "target": "ENSG00000158864"}], "drugs": [{"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}], "max_phase": 4, "name": "METFORMIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1703", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFS1", "NDUFB4", "NDUFS8", "NDUFS7", "NDUFA8", "NDUFA5", "NDUFA2", "NDUFB5", "NDUFAF1", "NDUFA9", "NDUFB10", "NDUFS6", "NDUFB9", "NDUFS2", "NDUFV3", "NDUFS4", "NDUFB6", "NDUFB8", "NDUFV1", "NDUFV2", "NDUFB1", "NDUFA12", "NDUFA6", "MT-ND6", "MT-ND5", "MT-ND4", "MT-ND1", "NDUFS3", "NDUFA7"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"]}, {"indications": [], "max_phase": 1, "name": "NV-128", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545135", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFS1", "NDUFB4", "NDUFS8", "NDUFS7", "NDUFA8", "NDUFA5", "NDUFA2", "NDUFB5", "NDUFAF1", "NDUFA9", "NDUFB10", "NDUFS6", "NDUFB9", "NDUFS2", "NDUFV3", "NDUFS4", "NDUFB6", "NDUFB8", "NDUFV1", "NDUFV2", "NDUFB1", "NDUFA12", "NDUFA6", "MT-ND6", "MT-ND5", "MT-ND4", "MT-ND1", "NDUFS3", "NDUFA7"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ME-344", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545320", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFS1", "NDUFB4", "NDUFS8", "NDUFS7", "NDUFA8", "NDUFA5", "NDUFA2", "NDUFB5", "NDUFAF1", "NDUFA9", "NDUFB10", "NDUFS6", "NDUFB9", "NDUFS2", "NDUFV3", "NDUFS4", "NDUFB6", "NDUFB8", "NDUFV1", "NDUFV2", "NDUFB1", "NDUFA12", "NDUFA6", "MT-ND6", "MT-ND5", "MT-ND4", "MT-ND1", "NDUFS3", "NDUFA7"], "type": "Small molecule", "diseases": []}], "heat": 0.6562286102150545, "nodes": [{"assoc": 0.7, "id": "ENSG00000023228", "label": "NDUFS1"}, {"assoc": 0.7, "id": "ENSG00000065518", "label": "NDUFB4"}, {"assoc": 0.7, "id": "ENSG00000110717", "label": "NDUFS8"}, {"assoc": 0.7, "id": "ENSG00000115286", "label": "NDUFS7"}, {"assoc": 0.7, "id": "ENSG00000119421", "label": "NDUFA8"}, {"assoc": 0.0430869166667, "id": "ENSG00000128311", "label": "TST"}, {"assoc": 0.7, "id": "ENSG00000128609", "label": "NDUFA5"}, {"assoc": 0.7, "id": "ENSG00000131495", "label": "NDUFA2"}, {"assoc": 0.7, "id": "ENSG00000136521", "label": "NDUFB5"}, {"assoc": 0.7, "id": "ENSG00000137806", "label": "NDUFAF1"}, {"assoc": 0.7, "id": "ENSG00000139180", "label": "NDUFA9"}, {"assoc": 0.7, "id": "ENSG00000140990", "label": "NDUFB10"}, {"assoc": 0.7, "id": "ENSG00000145494", "label": "NDUFS6"}, {"assoc": 0.7, "id": "ENSG00000147684", "label": "NDUFB9"}, {"assoc": 0.7, "id": "ENSG00000158864", "label": "NDUFS2"}, {"assoc": 0.7, "id": "ENSG00000160194", "label": "NDUFV3"}, {"assoc": 0.7, "id": "ENSG00000164258", "label": "NDUFS4"}, {"assoc": 0.7, "id": "ENSG00000165264", "label": "NDUFB6"}, {"assoc": 0.7, "id": "ENSG00000166136", "label": "NDUFB8"}, {"assoc": 0.7, "id": "ENSG00000167792", "label": "NDUFV1"}, {"assoc": 0.7, "id": "ENSG00000178127", "label": "NDUFV2"}, {"assoc": 0.7, "id": "ENSG00000183648", "label": "NDUFB1"}, {"assoc": 0.7, "id": "ENSG00000184752", "label": "NDUFA12"}, {"assoc": 0.7, "id": "ENSG00000184983", "label": "NDUFA6"}, {"assoc": 0.7, "id": "ENSG00000198695", "label": "MT-ND6"}, {"assoc": 0.7, "id": "ENSG00000198786", "label": "MT-ND5"}, {"assoc": 0.7, "id": "ENSG00000198886", "label": "MT-ND4"}, {"assoc": 0.7, "id": "ENSG00000198888", "label": "MT-ND1"}, {"assoc": 0.7, "id": "ENSG00000213619", "label": "NDUFS3"}, {"assoc": 0.7, "id": "ENSG00000267855", "label": "NDUFA7"}, {"assoc": 0, "id": "ENSG00000130159", "label": "ECSIT"}], "size": 31}, {"diseases": ["MULTIPLE MYELOMA", "ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "PSORIASIS", "CANCER", "NEOPLASM", "PRIMARY MYELOFIBROSIS", "LIVER DISEASE", "POLYCYTHEMIA VERA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "COLORECTAL ADENOCARCINOMA", "RHEUMATOID ARTHRITIS", "DIABETIC NEPHROPATHY", "SYSTEMIC LUPUS ERYTHEMATOSUS", "IMMUNE SYSTEM DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "NON-HODGKINS LYMPHOMA", "PSORIATIC ARTHRITIS", "ANKYLOSING SPONDYLITIS", "ATOPIC ECZEMA", "CROHN'S DISEASE", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "UVEITIS", "ULCERATIVE COLITIS", "HIDRADENITIS SUPPURATIVA", "MULTIPLE SCLEROSIS", "ASTHMA", "BEHCET'S SYNDROME", "ALOPECIA AREATA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "PYODERMA", "DRY EYE SYNDROME", "DIFFUSE SCLERODERMA", "VITILIGO", "HYPERTENSION", "CHRONIC CHILDHOOD ARTHRITIS", "WEGENER'S GRANULOMATOSIS", "ALOPECIA TOTALIS", "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "NEPHROTIC SYNDROME", "URTICARIA", "PROTEINURIA", "BREAST CARCINOMA", "GASTRIC ADENOCARCINOMA", "MELANOMA", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BREAST NEOPLASM", "BLADDER CARCINOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "OVARIAN CARCINOMA", "PANCREATIC DUCTAL ADENOCARCINOMA", "PROSTATE CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "COLORECTAL CANCER", "PANCREATIC CARCINOMA", "MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA", "LYMPHOID NEOPLASM", "MYELODYSPLASTIC SYNDROME", "OVARIAN NEOPLASM", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "MERKEL CELL SKIN CANCER", "NASOPHARYNGEAL NEOPLASM", "HODGKINS LYMPHOMA", "ENDOMETRIAL NEOPLASM", "LYMPHOMA", "CARCINOMA", "METASTATIC MELANOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "CUTANEOUS MELANOMA", "PROSTATE ADENOCARCINOMA", "SMALL CELL LUNG CARCINOMA", "LUNG CARCINOMA", "RENAL CARCINOMA", "HEPATITIS C INFECTION"], "links": [{"source": "ENSG00000056972", "type": "directed", "target": "ENSG00000101017"}, {"source": "ENSG00000056972", "target": "ENSG00000177663"}, {"source": "ENSG00000081985", "type": "stimulatory", "target": "ENSG00000096968", "reverse": "rev-directed"}, {"source": "ENSG00000081985", "type": "directed", "target": "ENSG00000113302", "reverse": "rev-directed"}, {"source": "ENSG00000081985", "type": "directed", "target": "ENSG00000168811", "reverse": "rev-stimulatory"}, {"source": "ENSG00000096968", "type": "directed", "target": "ENSG00000105639", "reverse": "rev-directed"}, {"source": "ENSG00000096968", "type": "stimulatory", "target": "ENSG00000162434", "reverse": "rev-stimulatory"}, {"source": "ENSG00000096968", "type": "stimulatory", "target": "ENSG00000162594", "reverse": "rev-stimulatory"}, {"source": "ENSG00000096968", "type": "dual", "target": "ENSG00000163599"}, {"source": "ENSG00000096968", "type": "stimulatory", "target": "ENSG00000170581"}, {"source": "ENSG00000101017", "target": "ENSG00000105639", "reverse": "rev-directed"}, {"source": "ENSG00000101017", "target": "ENSG00000162924", "reverse": "rev-directed"}, {"source": "ENSG00000105397", "target": "ENSG00000105639", "reverse": "rev-directed"}, {"source": "ENSG00000105397", "type": "directed", "target": "ENSG00000162434", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105397", "type": "stimulatory", "target": "ENSG00000162594", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105397", "type": "stimulatory", "target": "ENSG00000170581", "reverse": "rev-directed"}, {"source": "ENSG00000105397", "target": "ENSG00000185436", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105639", "type": "dual", "target": "ENSG00000162434", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105639", "type": "directed", "target": "ENSG00000175354", "reverse": "rev-dual"}, {"source": "ENSG00000110944", "type": "directed", "target": "ENSG00000113302", "reverse": "rev-directed"}, {"source": "ENSG00000110944", "type": "stimulatory", "target": "ENSG00000162594", "reverse": "rev-directed"}, {"source": "ENSG00000112115", "type": "stimulatory", "target": "ENSG00000177663", "reverse": "rev-inhibitory"}, {"source": "ENSG00000113302", "type": "stimulatory", "target": "ENSG00000162594", "reverse": "rev-directed"}, {"source": "ENSG00000113302", "target": "ENSG00000168811", "reverse": "rev-stimulatory"}, {"source": "ENSG00000114013", "type": "stimulatory", "target": "ENSG00000163599", "reverse": "rev-directed"}, {"source": "ENSG00000114013", "type": "stimulatory", "target": "ENSG00000178562", "reverse": "rev-directed"}, {"source": "ENSG00000120217", "type": "stimulatory", "target": "ENSG00000121594", "reverse": "rev-stimulatory"}, {"source": "ENSG00000121594", "type": "stimulatory", "target": "ENSG00000163599", "reverse": "rev-directed"}, {"source": "ENSG00000121594", "type": "stimulatory", "target": "ENSG00000178562", "reverse": "rev-stimulatory"}, {"source": "ENSG00000162434", "type": "stimulatory", "target": "ENSG00000170581", "reverse": "rev-directed"}, {"source": "ENSG00000162434", "type": "directed", "target": "ENSG00000175354", "reverse": "rev-dual"}, {"source": "ENSG00000162434", "target": "ENSG00000185436", "reverse": "rev-stimulatory"}, {"source": "ENSG00000163702", "target": "ENSG00000177663"}, {"source": "ENSG00000168811", "target": "ENSG00000178562"}, {"source": "ENSG00000182393", "type": "stimulatory", "target": "ENSG00000185436"}], "drugs": [{"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "DIFFUSE SCLERODERMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALOPECIA TOTALIS", "stage": 2}, {"efo_term": "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "VITILIGO", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "WEGENER'S GRANULOMATOSIS", "stage": 1}, {"efo_term": "URTICARIA", "stage": 1}], "max_phase": 4, "name": "ABATACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201823", "mechanisms": ["T-lymphocyte activation antigen CD86 inhibitor", "T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD86", "CD80"], "type": "Protein", "diseases": ["DIFFUSE SCLERODERMA", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "MULTIPLE SCLEROSIS", "VITILIGO", "HYPERTENSION", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ACUTE GRAFT VS. HOST DISEASE", "ALOPECIA AREATA", "TYPE I DIABETES MELLITUS", "ASTHMA", "CHRONIC CHILDHOOD ARTHRITIS", "WEGENER'S GRANULOMATOSIS", "ALOPECIA TOTALIS", "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "IMMUNE SYSTEM DISEASE", "PSORIASIS", "SARCOIDOSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "NEPHROTIC SYNDROME", "UVEITIS", "URTICARIA"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC DUCTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "COLORECTAL CANCER", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 1}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 1}], "max_phase": 3, "name": "DURVALUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301587", "mechanisms": ["Programmed cell death 1 ligand 1 inhibitor"], "genes": ["CD274"], "type": "Antibody", "diseases": ["BREAST CARCINOMA", "CANCER", "GASTRIC ADENOCARCINOMA", "NEOPLASM", "MELANOMA", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BREAST NEOPLASM", "BLADDER CARCINOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MULTIPLE MYELOMA", "OVARIAN CARCINOMA", "PANCREATIC DUCTAL ADENOCARCINOMA", "PRIMARY MYELOFIBROSIS", "PROSTATE CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "COLORECTAL CANCER", "PANCREATIC CARCINOMA", "MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 1}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "RENAL CARCINOMA", "stage": 1}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 1}], "max_phase": 4, "name": "IPILIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789844", "mechanisms": ["Cytotoxic T-lymphocyte protein 4 inhibitor"], "genes": ["CTLA4"], "type": "Antibody", "diseases": ["CANCER", "CARCINOMA", "MELANOMA", "PROSTATE CARCINOMA", "METASTATIC MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "CUTANEOUS MELANOMA", "PROSTATE ADENOCARCINOMA", "SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "LUNG CARCINOMA", "GASTRIC ADENOCARCINOMA", "RENAL CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MERKEL CELL SKIN CANCER"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "UVEITIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "PYODERMA", "stage": 1}], "max_phase": 4, "name": "SECUKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743068", "mechanisms": ["Interleukin 17A inhibitor"], "genes": ["IL17A"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "PSORIASIS", "TYPE I DIABETES MELLITUS", "MULTIPLE SCLEROSIS", "PSORIATIC ARTHRITIS", "ASTHMA", "RHEUMATOID ARTHRITIS", "IMMUNE SYSTEM DISEASE", "BEHCET'S SYNDROME", "ALOPECIA AREATA", "CROHN'S DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "PYODERMA", "ATOPIC ECZEMA", "UVEITIS", "DRY EYE SYNDROME"]}, {"indications": [{"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "METASTATIC MELANOMA", "stage": 1}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 1}, {"efo_term": "LYMPHOMA", "stage": 1}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}], "max_phase": 3, "name": "TREMELIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108658", "mechanisms": ["Cytotoxic T-lymphocyte protein 4 inhibitor"], "genes": ["CTLA4"], "type": "Antibody", "diseases": ["HEPATOCELLULAR CARCINOMA", "MESOTHELIOMA", "BREAST CARCINOMA", "MELANOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "METASTATIC MELANOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "GLIOBLASTOMA MULTIFORME", "GASTRIC ADENOCARCINOMA", "LYMPHOMA", "MYELODYSPLASTIC SYNDROME"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "USTEKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201835", "mechanisms": ["Interleukin-23 inhibitor", "Interleukin-12 inhibitor"], "genes": ["IL23A", "IL12B", "IL12A"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "ATOPIC ECZEMA", "PSORIASIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "UVEITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ULCERATIVE COLITIS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "MERKEL CELL SKIN CANCER", "stage": 4}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "OVARIAN CARCINOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "AVELUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833373", "mechanisms": ["Programmed cell death 1 ligand 1 other"], "genes": ["CD274"], "type": "Antibody", "diseases": ["MERKEL CELL SKIN CANCER", "GASTRIC ADENOCARCINOMA", "GLIOBLASTOMA MULTIFORME", "CANCER", "NON-SMALL CELL LUNG CARCINOMA", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM", "OVARIAN CARCINOMA", "BREAST NEOPLASM", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "HODGKINS LYMPHOMA", "ENDOMETRIAL NEOPLASM"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "OVARIAN NEOPLASM", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 1}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "ATEZOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707227", "mechanisms": ["Programmed cell death 1 ligand 1 inhibitor"], "genes": ["CD274"], "type": "Antibody", "diseases": ["CANCER", "COLORECTAL ADENOCARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "LYMPHOID NEOPLASM", "MYELODYSPLASTIC SYNDROME", "BREAST CARCINOMA", "NEOPLASM", "OVARIAN NEOPLASM", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "BLADDER CARCINOMA", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "BRODALUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742996", "mechanisms": ["Interleukin-17 receptor A antagonist"], "genes": ["IL17RA"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "PSORIASIS", "RHEUMATOID ARTHRITIS", "PSORIATIC ARTHRITIS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 4, "name": "BARICITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105759", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor", "Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK2", "JAK1"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "DIABETIC NEPHROPATHY", "SYSTEMIC LUPUS ERYTHEMATOSUS", "PSORIASIS", "IMMUNE SYSTEM DISEASE", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 4, "name": "IXEKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743034", "mechanisms": ["Interleukin 17A inhibitor"], "genes": ["IL17A"], "type": "Antibody", "diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "PSORIATIC ARTHRITIS", "IMMUNE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 3, "name": "BRIAKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742995", "mechanisms": ["Interleukin-23 inhibitor", "Interleukin-12 inhibitor", "Interleukin-12 subunit beta inhibitor"], "genes": ["IL23A", "IL12B", "IL12A"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "PSORIASIS", "MULTIPLE SCLEROSIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 3, "name": "LESTAURTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603469", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "PSORIASIS"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "FEDRATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1287853", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["NEOPLASM", "PRIMARY MYELOFIBROSIS", "LIVER DISEASE"]}, {"indications": [{"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}], "max_phase": 3, "name": "PACRITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2035187", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["COLORECTAL ADENOCARCINOMA", "PRIMARY MYELOFIBROSIS", "LEUKEMIA"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 2, "name": "DACETUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743005", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 inhibitor"], "genes": ["CD40"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}], "max_phase": 4, "name": "BELATACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742990", "mechanisms": ["T-lymphocyte activation antigen CD86 inhibitor", "T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD86", "CD80"], "type": "Protein", "diseases": ["IMMUNE SYSTEM DISEASE", "PROTEINURIA", "TYPE I DIABETES MELLITUS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}], "max_phase": 2, "name": "SOLCITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301606", "mechanisms": ["Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK1"], "type": "Small molecule", "diseases": ["PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ULCERATIVE COLITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}], "max_phase": 3, "name": "FILGOTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301607", "mechanisms": ["Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK1"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "ULCERATIVE COLITIS"]}, {"indications": [{"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 4}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 4}], "max_phase": 4, "name": "RUXOLITINIB PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795071", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor", "Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK2", "JAK1"], "type": "Small molecule", "diseases": ["PRIMARY MYELOFIBROSIS", "POLYCYTHEMIA VERA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 3, "name": "PEFICITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137308", "mechanisms": ["Janus Kinase (JAK) inhibitor"], "genes": ["JAK2", "TYK2", "JAK3", "JAK1"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "PSORIASIS"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 3, "name": "GALIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109191", "mechanisms": ["T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD80"], "type": "Antibody", "diseases": ["LYMPHOMA", "NON-HODGKINS LYMPHOMA"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "PF-04965842", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544929", "mechanisms": ["Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "PSORIASIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}], "max_phase": 2, "name": "INCB-047986", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545225", "mechanisms": ["Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK1"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "MYELODYSPLASTIC SYNDROME"]}, {"indications": [{"efo_term": "MULTIPLE MYELOMA", "stage": 2}], "max_phase": 2, "name": "AT-9283", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495727", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor", "Tyrosine-protein kinase JAK3 inhibitor"], "genes": ["JAK2", "JAK3"], "type": "Small molecule", "diseases": ["MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "AZD-1480", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1231124", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 1, "name": "TG-02", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1944698", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "BMS-911543", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545215", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 1, "name": "AC-430", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545241", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "POLYCYTHEMIA VERA", "stage": 1}], "max_phase": 1, "name": "XL-019", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545328", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": ["POLYCYTHEMIA VERA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}], "max_phase": 4, "name": "TOFACITINIB CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103743", "mechanisms": ["Janus Kinase (JAK) inhibitor"], "genes": ["JAK2", "TYK2", "JAK3", "JAK1"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "PSORIATIC ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PG-102", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109475", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 inhibitor"], "genes": ["CD40"], "type": "Antibody", "diseases": ["PSORIATIC ARTHRITIS"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "Cerdulatinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545284", "mechanisms": ["Tyrosine-protein kinase TYK2  inhibitor", "Tyrosine-protein kinase JAK3 inhibitor", "Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["TYK2", "JAK3", "JAK1"], "type": "Small molecule", "diseases": ["NON-HODGKINS LYMPHOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "DECERNOTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039513", "mechanisms": ["Tyrosine-protein kinase JAK3 inhibitor"], "genes": ["JAK3"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}], "max_phase": 2, "name": "R-333", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545159", "mechanisms": ["Tyrosine-protein kinase JAK3 inhibitor"], "genes": ["JAK3"], "type": "Small molecule", "diseases": ["SYSTEMIC LUPUS ERYTHEMATOSUS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "TILDRAKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108681", "mechanisms": ["Interleukin-23 subunit alpha inhibitor"], "genes": ["IL23A"], "type": "Antibody", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "GUSELKUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364648", "mechanisms": ["Interleukin-23 subunit alpha inhibitor"], "genes": ["IL23A"], "type": "Antibody", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "HEPATITIS C INFECTION", "stage": 1}], "max_phase": 3, "name": "PEGINTERFERON LAMBDA-1A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108723", "mechanisms": ["Interferon lambda receptor agonist"], "genes": ["IFNLR1"], "type": "Protein", "diseases": ["HEPATITIS C INFECTION"]}, {"indications": [], "max_phase": 3, "name": "MOMELOTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1078178", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor", "Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK2", "JAK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GANDOTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107823", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CT-1578", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544962", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LS-104", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544997", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NS-018", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545217", "mechanisms": ["Tyrosine-protein kinase JAK2 inhibitor"], "genes": ["JAK2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TENELIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108144", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 partial agonist"], "genes": ["CD40"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "WHI-P131", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405130", "mechanisms": ["Tyrosine-protein kinase JAK3 inhibitor"], "genes": ["JAK3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TRICETAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106468", "mechanisms": ["Tyrosine-protein kinase JAK3 inhibitor", "Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK3", "JAK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "R-348", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545382", "mechanisms": ["Tyrosine-protein kinase JAK3 inhibitor"], "genes": ["JAK3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GLPG-0555", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545249", "mechanisms": ["Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ITACITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3622820", "mechanisms": ["Tyrosine-protein kinase JAK1  inhibitor"], "genes": ["JAK1"], "type": "Small molecule", "diseases": []}], "heat": 0.6939362642223875, "nodes": [{"assoc": 1.0, "id": "ENSG00000056972", "label": "TRAF3IP2"}, {"assoc": 0.412041002225, "id": "ENSG00000081985", "label": "IL12RB2"}, {"assoc": 1.0, "id": "ENSG00000096968", "label": "JAK2"}, {"assoc": 0.508288051533, "id": "ENSG00000101017", "label": "CD40"}, {"assoc": 1.0, "id": "ENSG00000105397", "label": "TYK2"}, {"assoc": 1.0, "id": "ENSG00000105639", "label": "JAK3"}, {"assoc": 1.0, "id": "ENSG00000110944", "label": "IL23A"}, {"assoc": 1.0, "id": "ENSG00000112115", "label": "IL17A"}, {"assoc": 1.0, "id": "ENSG00000113302", "label": "IL12B"}, {"assoc": 0.277404399317, "id": "ENSG00000114013", "label": "CD86"}, {"assoc": 0.0684828122815, "id": "ENSG00000120217", "label": "CD274"}, {"assoc": 0.277910201338, "id": "ENSG00000121594", "label": "CD80"}, {"assoc": 1.0, "id": "ENSG00000162434", "label": "JAK1"}, {"assoc": 1.0, "id": "ENSG00000162594", "label": "IL23R"}, {"assoc": 0.699254787527, "id": "ENSG00000162924", "label": "REL"}, {"assoc": 0.402604004243, "id": "ENSG00000163599", "label": "CTLA4"}, {"assoc": 0.018612, "id": "ENSG00000163702", "label": "IL17RC"}, {"assoc": 1.0, "id": "ENSG00000168811", "label": "IL12A"}, {"assoc": 0.967410467719, "id": "ENSG00000170581", "label": "STAT2"}, {"assoc": 0.821495642742, "id": "ENSG00000175354", "label": "PTPN2"}, {"assoc": 1.0, "id": "ENSG00000177663", "label": "IL17RA"}, {"assoc": 0.518208387228, "id": "ENSG00000178562", "label": "CD28"}, {"assoc": 0.0544867777778, "id": "ENSG00000182393", "label": "IFNL1"}, {"assoc": 0.628271807406, "id": "ENSG00000185436", "label": "IFNLR1"}], "size": 24}, {"diseases": ["OSTEOSARCOMA", "DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"], "links": [{"source": "ENSG00000057663", "type": "stimulatory", "target": "ENSG00000085978", "reverse": "rev-directed"}, {"source": "ENSG00000057663", "type": "directed", "target": "ENSG00000107201", "reverse": "rev-directed"}, {"source": "ENSG00000057663", "type": "directed", "target": "ENSG00000115267", "reverse": "rev-directed"}, {"source": "ENSG00000085978", "target": "ENSG00000167207", "reverse": "rev-stimulatory"}, {"source": "ENSG00000107201", "type": "inhibitory", "target": "ENSG00000115267", "reverse": "rev-inhibitory"}, {"source": "ENSG00000107201", "type": "directed", "target": "ENSG00000167207"}, {"source": "ENSG00000111335", "target": "ENSG00000167207", "reverse": "rev-directed"}, {"source": "ENSG00000113522", "target": "ENSG00000187796", "reverse": "rev-directed"}, {"source": "ENSG00000140279", "type": "directed", "target": "ENSG00000167207"}, {"source": "ENSG00000167207", "type": "directed", "target": "ENSG00000186010"}, {"source": "ENSG00000167207", "type": "directed", "target": "ENSG00000187796"}], "drugs": [{"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}], "max_phase": 4, "name": "METFORMIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1703", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFA13"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"]}, {"indications": [{"efo_term": "OSTEOSARCOMA", "stage": 2}], "max_phase": 4, "name": "MIFAMURTIDE SODIUM HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107354", "mechanisms": ["Nucleotide-binding oligomerization domain-containing protein 2 other"], "genes": ["NOD2"], "type": "Small molecule", "diseases": ["OSTEOSARCOMA"]}, {"indications": [], "max_phase": 1, "name": "NV-128", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545135", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFA13"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ME-344", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545320", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFA13"], "type": "Small molecule", "diseases": []}], "heat": 0.6310143351580401, "nodes": [{"assoc": 0.3996134458, "id": "ENSG00000057663", "label": "ATG5"}, {"assoc": 0.7663831918, "id": "ENSG00000085978", "label": "ATG16L1"}, {"assoc": 0.680895732269, "id": "ENSG00000107201", "label": "DDX58"}, {"assoc": 0.104215903609, "id": "ENSG00000111335", "label": "OAS2"}, {"assoc": 0.65, "id": "ENSG00000113522", "label": "RAD50"}, {"assoc": 0.942142633658, "id": "ENSG00000115267", "label": "IFIH1"}, {"assoc": 0.0668924444444, "id": "ENSG00000140279", "label": "DUOX2"}, {"assoc": 1.0, "id": "ENSG00000167207", "label": "NOD2"}, {"assoc": 0.7, "id": "ENSG00000186010", "label": "NDUFA13"}, {"assoc": 1.0, "id": "ENSG00000187796", "label": "CARD9"}], "size": 10}, {"diseases": ["ACNE", "ACUTE MYELOID LEUKEMIA", "LYMPHOMA", "NEOPLASM", "ROSACEA", "MULTIPLE MYELOMA", "LUNG CARCINOMA", "ACTINIC KERATOSIS", "NEUROBLASTOMA", "INFECTION", "HIV-1 INFECTION", "ALZHEIMERS DISEASE", "SKIN DISEASE", "PSORIASIS", "CARCINOMA", "ECZEMA", "CUTANEOUS LUPUS ERYTHEMATOSUS", "BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "BONE FRACTURE", "APHTHOUS ULCER", "BLADDER CARCINOMA", "INFLAMMATORY BOWEL DISEASE", "HYPERPARATHYROIDISM", "OSTEOPENIA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "OSTEOARTHRITIS", "ULCERATIVE COLITIS", "SARCOPENIA", "CANCER", "POLYCYSTIC OVARY SYNDROME", "RESTLESS LEGS SYNDROME", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "SECONDARY HYPERPARATHYROIDISM", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "SYSTEMIC SCLERODERMA", "MYOCARDIAL INFARCTION", "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA", "SCHIZOPHRENIA", "ALOPECIA AREATA", "THYROID CARCINOMA", "CUTANEOUS T-CELL LYMPHOMA"], "links": [{"source": "ENSG00000077092", "type": "directed", "target": "ENSG00000143171"}, {"source": "ENSG00000077092", "type": "stimulatory", "target": "ENSG00000186350", "reverse": "rev-stimulatory"}, {"source": "ENSG00000077092", "type": "stimulatory", "target": "ENSG00000204231", "reverse": "rev-stimulatory"}, {"source": "ENSG00000111424", "type": "stimulatory", "target": "ENSG00000186350", "reverse": "rev-stimulatory"}, {"source": "ENSG00000111424", "type": "stimulatory", "target": "ENSG00000204231", "reverse": "rev-stimulatory"}, {"source": "ENSG00000112033", "type": "directed", "target": "ENSG00000143171"}, {"source": "ENSG00000112033", "type": "stimulatory", "target": "ENSG00000186350", "reverse": "rev-stimulatory"}, {"source": "ENSG00000112033", "type": "stimulatory", "target": "ENSG00000204231", "reverse": "rev-stimulatory"}, {"source": "ENSG00000131759", "type": "stimulatory", "target": "ENSG00000143171"}, {"source": "ENSG00000131759", "type": "stimulatory", "target": "ENSG00000186350", "reverse": "rev-stimulatory"}, {"source": "ENSG00000131759", "type": "stimulatory", "target": "ENSG00000204231", "reverse": "rev-stimulatory"}, {"source": "ENSG00000143171", "target": "ENSG00000172819", "reverse": "rev-directed"}, {"source": "ENSG00000172819", "type": "stimulatory", "target": "ENSG00000186350", "reverse": "rev-dual"}, {"source": "ENSG00000172819", "type": "stimulatory", "target": "ENSG00000204231", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "VITAMIN D DEFICIENCY", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "INFLUENZA INFECTION", "stage": 3}, {"efo_term": "COLORECTAL ADENOMA", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "INFECTION", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "HYPOGONADISM", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "RESPIRATORY TRACT INFECTION", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ABNORMAL GLUCOSE TOLERANCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "AIDS", "stage": 2}, {"efo_term": "METABOLIC SYNDROME", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "AGING", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}, {"efo_term": "TIBIA FRACTURE", "stage": 1}, {"efo_term": "PNEUMONIA", "stage": 1}, {"efo_term": "SKIN NEOPLASM", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 1}, {"efo_term": "HYPERLIPIDEMIA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 0}], "max_phase": 4, "name": "CHOLECALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "SYSTEMIC LUPUS ERYTHEMATOSUS", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "PROSTATE CARCINOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "OSTEOPOROSIS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "TYPE I DIABETES MELLITUS", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ATOPIC ECZEMA", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "APHTHOUS ULCER", "stage": 3}, {"efo_term": "VITAMIN D DEFICIENCY", "stage": 3}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}, {"efo_term": "INFLAMMATORY BOWEL DISEASE", "stage": 1}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "SARCOPENIA", "stage": 1}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 1}, {"efo_term": "OSTEOPENIA", "stage": 0}], "max_phase": 4, "name": "ERGOCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1536", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "BREAST NEOPLASM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "APHTHOUS ULCER", "VITAMIN D DEFICIENCY", "BLADDER CARCINOMA", "TYPE I DIABETES MELLITUS", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "TYPE II DIABETES MELLITUS", "INFLAMMATORY BOWEL DISEASE", "MULTIPLE SCLEROSIS", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "PROSTATE ADENOCARCINOMA", "OBESITY", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "HIV INFECTION", "NON-ALCOHOLIC FATTY LIVER DISEASE", "HEART FAILURE", "OSTEOARTHRITIS", "SICKLE CELL ANEMIA", "ULCERATIVE COLITIS", "SARCOPENIA", "TUBERCULOSIS", "CANCER", "POLYCYSTIC OVARY SYNDROME", "PREGNANCY", "RESTLESS LEGS SYNDROME", "OPTIC NEURITIS", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "ASTHMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "HYPOPARATHYROIDISM", "stage": 4}, {"efo_term": "HYPOCALCEMIA", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 3}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "MENOPAUSE", "stage": 1}], "max_phase": 4, "name": "CALCITRIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "CUTANEOUS T-CELL LYMPHOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "THYROID CARCINOMA", "stage": 0}], "max_phase": 4, "name": "BEXAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023", "mechanisms": ["Retinoid X receptor agonist"], "genes": ["RXRG", "RXRA", "RXRB"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ACUTE MYELOID LEUKEMIA", "ALOPECIA AREATA", "THYROID CARCINOMA", "BREAST CARCINOMA", "CUTANEOUS T-CELL LYMPHOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEUROBLASTOMA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ACTINIC KERATOSIS", "stage": 2}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "INFECTION", "stage": 1}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 4, "name": "ISOTRETINOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARA", "RARG"], "type": "Small molecule", "diseases": ["LUNG CARCINOMA", "ACTINIC KERATOSIS", "NEUROBLASTOMA", "ACNE", "INFECTION", "HIV-1 INFECTION", "ALZHEIMERS DISEASE", "ROSACEA"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 4}, {"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 4}, {"efo_term": "IGA GLOMERULONEPHRITIS", "stage": 3}, {"efo_term": "PROTEINURIA", "stage": 3}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}], "max_phase": 4, "name": "PARICALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200622", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "TYPE II DIABETES MELLITUS", "SECONDARY HYPERPARATHYROIDISM", "HYPERPARATHYROIDISM", "ALLERGY"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}], "max_phase": 4, "name": "TRETINOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARA", "RARG"], "type": "Small molecule", "diseases": ["ACNE", "ACUTE MYELOID LEUKEMIA", "LYMPHOMA", "NEOPLASM", "ROSACEA", "MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "SKIN DISEASE", "stage": 2}], "max_phase": 4, "name": "TAZAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARA", "RARG"], "type": "Small molecule", "diseases": ["ACNE", "PSORIASIS", "CARCINOMA", "SKIN DISEASE"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ECZEMA", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}], "max_phase": 4, "name": "ALITRETINOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705", "mechanisms": ["Retinoid receptor agonist"], "genes": ["RARB", "RARA", "RXRG", "RARG", "RXRA", "RXRB"], "type": "Small molecule", "diseases": ["NEOPLASM", "PSORIASIS", "ECZEMA", "CUTANEOUS LUPUS ERYTHEMATOSUS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "CALCIPOTRIENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200666", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "ACNE", "SYSTEMIC SCLERODERMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "DOXERCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200810", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "NEOPLASM", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "ADAPALENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265", "mechanisms": ["Retinoic acid receptor agonist"], "genes": ["RARB", "RARA", "RARG"], "type": "Small molecule", "diseases": ["ACNE", "SKIN DISEASE"]}, {"indications": [{"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 2}, {"efo_term": "OSTEOPOROSIS", "stage": 2}], "max_phase": 2, "name": "DP001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605525", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["SECONDARY HYPERPARATHYROIDISM", "OSTEOPOROSIS"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}], "max_phase": 4, "name": "CALCIFEDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544909", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "HYPERLIPIDEMIA", "stage": 2}, {"efo_term": "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 2}], "max_phase": 2, "name": "MBX-8025", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545019", "mechanisms": ["Peroxisome proliferator-activated receptor delta agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": ["HYPERLIPIDEMIA", "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}], "max_phase": 4, "name": "ETRETINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464", "mechanisms": ["Retinoid receptor agonist"], "genes": ["RARB", "RARA", "RXRG", "RARG", "RXRA", "RXRB"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}], "max_phase": 4, "name": "ACITRETIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131", "mechanisms": ["Retinoid receptor agonist"], "genes": ["RARB", "RARA", "RXRG", "RARG", "RXRA", "RXRB"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "BECOCALCIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104955", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}], "max_phase": 2, "name": "INECALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105107", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "PEFCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137307", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "IRX-4204", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75133", "mechanisms": ["Retinoid X receptor agonist"], "genes": ["RXRG", "RXRA", "RXRB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [], "max_phase": 1, "name": "IRX4310", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545173", "mechanisms": ["Retinoic acid receptor antagonist"], "genes": ["RARB", "RARA", "RARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "MOFAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146506", "mechanisms": ["Retinoid receptor modulator"], "genes": ["RARB", "RARA", "RXRG", "RARG", "RXRA", "RXRB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ILX23-7553", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284121", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SEOCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908376", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "LUNACALCIPOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105705", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Elocalcitol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545094", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CER-002", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544958", "mechanisms": ["Peroxisome proliferator-activated receptor delta agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "KD3010", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545114", "mechanisms": ["Peroxisome proliferator-activated receptor delta agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DB959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545176", "mechanisms": ["Peroxisome proliferator-activated receptor delta agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AVE0847", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545295", "mechanisms": ["Peroxisome proliferator-activated receptor delta agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "INDEGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232583", "mechanisms": ["Peroxisome proliferator-activated receptor agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SODELGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104984", "mechanisms": ["Peroxisome proliferator-activated receptor agonist"], "genes": ["PPARD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NRX195183", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107430", "mechanisms": ["Retinoic acid receptor alpha agonist"], "genes": ["RARA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PALOVAROTENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105648", "mechanisms": ["Retinoic acid receptor gamma agonist"], "genes": ["RARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SDX-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1716091", "mechanisms": ["Retinoid X receptor alpha modulator"], "genes": ["RXRA"], "type": "Small molecule", "diseases": []}], "heat": 0.9045344908685, "nodes": [{"assoc": 1.0, "id": "ENSG00000077092", "label": "RARB"}, {"assoc": 1.0, "id": "ENSG00000111424", "label": "VDR"}, {"assoc": 0.236275926948, "id": "ENSG00000112033", "label": "PPARD"}, {"assoc": 1.0, "id": "ENSG00000131759", "label": "RARA"}, {"assoc": 1.0, "id": "ENSG00000143171", "label": "RXRG"}, {"assoc": 1.0, "id": "ENSG00000172819", "label": "RARG"}, {"assoc": 1.0, "id": "ENSG00000186350", "label": "RXRA"}, {"assoc": 1.0, "id": "ENSG00000204231", "label": "RXRB"}], "size": 8}, {"diseases": ["HEPATITIS B INFECTION", "FRIEDREICH ATAXIA", "RETINOPATHY", "ACUTE GRAFT VS. HOST DISEASE", "ANKYLOSING SPONDYLITIS", "CHRONIC CHILDHOOD ARTHRITIS", "DERMATOMYOSITIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "SUBARACHNOID HEMORRHAGE", "TYPE I DIABETES MELLITUS", "SCIATICA", "CHRONIC KIDNEY DISEASE", "LEUKEMIA", "URTICARIA", "ISCHEMIA REPERFUSION INJURY", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PNEUMONIA", "ALZHEIMERS DISEASE", "LICHEN PLANUS", "HIDRADENITIS SUPPURATIVA", "INCLUSION BODY MYOSITIS", "ULCERATIVE COLITIS", "CROHN'S DISEASE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "OSTEOARTHRITIS", "PSORIATIC ARTHRITIS", "NETHERTON SYNDROME", "SARCOIDOSIS", "PYODERMA", "COLITIS", "UVEITIS", "CHRONIC INTERSTITIAL CYSTITIS", "PAIN", "ENDOMETRIOSIS", "HEPATITIS C INFECTION", "EOSINOPHILIC ESOPHAGITIS", "SPONDYLOARTHROPATHY", "BERYLLIOSIS", "BEHCET'S SYNDROME", "BIPOLAR DISORDER", "DIABETIC RETINOPATHY", "ASTHMA"], "links": [{"source": "ENSG00000100292", "type": "inhibitory", "target": "ENSG00000232810", "reverse": "rev-directed"}, {"source": "ENSG00000111537", "type": "stimulatory", "target": "ENSG00000159128", "reverse": "rev-directed"}, {"source": "ENSG00000111537", "type": "stimulatory", "target": "ENSG00000232810", "reverse": "rev-inhibitory"}, {"source": "ENSG00000118503", "type": "directed", "target": "ENSG00000145901"}, {"source": "ENSG00000118503", "type": "stimulatory", "target": "ENSG00000232810", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "PNEUMONIA", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "URTICARIA", "stage": 2}, {"efo_term": "ISCHEMIA REPERFUSION INJURY", "stage": 2}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "LICHEN PLANUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "DERMATOMYOSITIS", "stage": 1}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 1}, {"efo_term": "SCIATICA", "stage": 1}, {"efo_term": "INCLUSION BODY MYOSITIS", "stage": 0}], "max_phase": 4, "name": "ETANERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201572", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": ["ACUTE GRAFT VS. HOST DISEASE", "ANKYLOSING SPONDYLITIS", "CHRONIC CHILDHOOD ARTHRITIS", "DERMATOMYOSITIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "SUBARACHNOID HEMORRHAGE", "TYPE I DIABETES MELLITUS", "SCIATICA", "CHRONIC KIDNEY DISEASE", "LEUKEMIA", "URTICARIA", "ISCHEMIA REPERFUSION INJURY", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PNEUMONIA", "ALZHEIMERS DISEASE", "LICHEN PLANUS", "HIDRADENITIS SUPPURATIVA", "INCLUSION BODY MYOSITIS"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 3}, {"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 3}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "EOSINOPHILIC ESOPHAGITIS", "stage": 2}, {"efo_term": "SPONDYLOARTHROPATHY", "stage": 2}, {"efo_term": "COLITIS", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "BERYLLIOSIS", "stage": 1}, {"efo_term": "UVEITIS", "stage": 1}], "max_phase": 4, "name": "INFLIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201581", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "ENDOMETRIOSIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "ULCERATIVE COLITIS", "HEPATITIS C INFECTION", "EOSINOPHILIC ESOPHAGITIS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PSORIATIC ARTHRITIS", "SPONDYLOARTHROPATHY", "BERYLLIOSIS", "BEHCET'S SYNDROME", "COLITIS", "BIPOLAR DISORDER", "ACUTE GRAFT VS. HOST DISEASE", "DIABETIC RETINOPATHY", "UVEITIS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 3}, {"efo_term": "UVEITIS", "stage": 3}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}, {"efo_term": "NETHERTON SYNDROME", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "PYODERMA", "stage": 2}, {"efo_term": "COLITIS", "stage": 2}], "max_phase": 4, "name": "ADALIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201580", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "ULCERATIVE COLITIS", "CROHN'S DISEASE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "OSTEOARTHRITIS", "PSORIATIC ARTHRITIS", "NETHERTON SYNDROME", "SARCOIDOSIS", "CHRONIC CHILDHOOD ARTHRITIS", "PYODERMA", "COLITIS", "HIDRADENITIS SUPPURATIVA", "UVEITIS", "CHRONIC INTERSTITIAL CYSTITIS", "PAIN"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}], "max_phase": 4, "name": "CERTOLIZUMAB PEGOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201831", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "CHRONIC CHILDHOOD ARTHRITIS", "PSORIASIS", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "SPONDYLOARTHROPATHY", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}], "max_phase": 4, "name": "GOLIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201833", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "SPONDYLOARTHROPATHY", "ULCERATIVE COLITIS", "ANKYLOSING SPONDYLITIS", "ASTHMA", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS"]}, {"indications": [{"efo_term": "HEPATITIS B INFECTION", "stage": 2}, {"efo_term": "FRIEDREICH ATAXIA", "stage": 2}, {"efo_term": "RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "INTERFERON GAMA-1B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201564", "mechanisms": ["Interferon gamma receptor agonist"], "genes": ["IFNGR2"], "type": "Protein", "diseases": ["HEPATITIS B INFECTION", "FRIEDREICH ATAXIA", "RETINOPATHY"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "SCIATICA", "stage": 1}], "max_phase": 2, "name": "PLACULUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108739", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "SCIATICA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "OZORALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743054", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}], "max_phase": 3, "name": "ONERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107911", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": ["PSORIATIC ARTHRITIS"]}, {"indications": [], "max_phase": 2, "name": "FONTOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108459", "mechanisms": ["Interferon gamma inhibitor"], "genes": ["IFNG"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PEGSUNERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743057", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 3, "name": "LENERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108208", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 3, "name": "NERELIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108566", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AFELIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108887", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZ-9773", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109587", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": []}], "heat": 0.7480226757301667, "nodes": [{"assoc": 0.141453332058, "id": "ENSG00000100292", "label": "HMOX1"}, {"assoc": 0.565614694879, "id": "ENSG00000111537", "label": "IFNG"}, {"assoc": 1.0, "id": "ENSG00000118503", "label": "TNFAIP3"}, {"assoc": 0.980336038182, "id": "ENSG00000145901", "label": "TNIP1"}, {"assoc": 0.800731989262, "id": "ENSG00000159128", "label": "IFNGR2"}, {"assoc": 1.0, "id": "ENSG00000232810", "label": "TNF"}], "size": 6}, {"diseases": ["PSORIASIS", "TYPE I DIABETES MELLITUS", "ALOPECIA TOTALIS", "DIABETIC RETINOPATHY", "IMMUNE SYSTEM DISEASE", "SJOGREN SYNDROME", "DRY EYE SYNDROME", "ALLERGIC CONJUNCTIVITIS", "NON-HODGKINS LYMPHOMA"], "links": [{"source": "ENSG00000005844", "target": "ENSG00000105376", "reverse": "rev-stimulatory"}, {"source": "ENSG00000005844", "type": "directed", "target": "ENSG00000160255", "reverse": "rev-directed"}, {"source": "ENSG00000105376", "type": "stimulatory", "target": "ENSG00000160255"}, {"source": "ENSG00000150637", "target": "ENSG00000160255", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "ALOPECIA TOTALIS", "stage": 2}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "EFALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201575", "mechanisms": ["Integrin alpha-L/beta-2 (LFA-1) inhibitor"], "genes": ["ITGAL", "ITGB2"], "type": "Antibody", "diseases": ["PSORIASIS", "TYPE I DIABETES MELLITUS", "ALOPECIA TOTALIS", "DIABETIC RETINOPATHY", "IMMUNE SYSTEM DISEASE", "SJOGREN SYNDROME"]}, {"indications": [{"efo_term": "DRY EYE SYNDROME", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}], "max_phase": 4, "name": "LIFITEGRAST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048028", "mechanisms": ["Integrin alpha-L/beta-2 (LFA-1) antagonist"], "genes": ["ITGAL", "ITGB2"], "type": "Small molecule", "diseases": ["DRY EYE SYNDROME", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "AME-133v", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109346", "mechanisms": ["Integrin beta-2 inhibitor"], "genes": ["ITGB2"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA"]}, {"indications": [], "max_phase": 3, "name": "ODULIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109177", "mechanisms": ["Leukocyte adhesion glycoprotein LFA-1 alpha inhibitor"], "genes": ["ITGAL"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ROVELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109224", "mechanisms": ["Integrin alpha-L/beta-2 (LFA-1) antagonist", "Integrin alpha-M/beta-2 antagonist"], "genes": ["ITGAL", "ITGB2"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ERLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109095", "mechanisms": ["Integrin beta-2 negative modulator"], "genes": ["ITGB2"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MLNM-2201", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109332", "mechanisms": ["Integrin beta-2 inhibitor"], "genes": ["ITGB2"], "type": "Antibody", "diseases": []}], "heat": 0.656204528125, "nodes": [{"assoc": 1.0, "id": "ENSG00000005844", "label": "ITGAL"}, {"assoc": 0.282658079, "id": "ENSG00000105376", "label": "ICAM5"}, {"assoc": 0.3421600335, "id": "ENSG00000150637", "label": "CD226"}, {"assoc": 1.0, "id": "ENSG00000160255", "label": "ITGB2"}], "size": 4}, {"diseases": ["ACNE", "PYODERMA", "PSORIASIS", "CANCER", "TYPE II DIABETES MELLITUS", "HIDRADENITIS SUPPURATIVA", "DIABETES MELLITUS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS", "CINCA SYNDROME", "HEART FAILURE", "CHRONIC CHILDHOOD ARTHRITIS", "CHRONIC KIDNEY DISEASE", "FAMILIAL MEDITERRANEAN FEVER", "MYOCARDIAL INFARCTION", "PULMONARY HYPERTENSION", "BLEPHARITIS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "CHRONIC FATIGUE SYNDROME", "INJURY", "IMMUNE SYSTEM DISEASE", "METABOLIC SYNDROME", "UVEITIS"], "links": [{"source": "ENSG00000115008", "type": "stimulatory", "target": "ENSG00000115590", "reverse": "rev-directed"}, {"source": "ENSG00000115008", "type": "stimulatory", "target": "ENSG00000115594", "reverse": "rev-directed"}, {"source": "ENSG00000115594", "target": "ENSG00000136697"}], "drugs": [{"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "CINCA SYNDROME", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 3}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 2}, {"efo_term": "CHRONIC FATIGUE SYNDROME", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "BLEPHARITIS", "stage": 1}, {"efo_term": "INJURY", "stage": 1}], "max_phase": 4, "name": "ANAKINRA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201570", "mechanisms": ["Interleukin-1 receptor antagonist"], "genes": ["IL1R1"], "type": "Protein", "diseases": ["DIABETES MELLITUS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS", "CINCA SYNDROME", "HEART FAILURE", "CHRONIC CHILDHOOD ARTHRITIS", "CHRONIC KIDNEY DISEASE", "FAMILIAL MEDITERRANEAN FEVER", "MYOCARDIAL INFARCTION", "PULMONARY HYPERTENSION", "BLEPHARITIS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "CHRONIC FATIGUE SYNDROME", "INJURY", "IMMUNE SYSTEM DISEASE", "METABOLIC SYNDROME", "HIDRADENITIS SUPPURATIVA", "UVEITIS"]}, {"indications": [{"efo_term": "ACNE", "stage": 2}, {"efo_term": "PYODERMA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 3, "name": "RA-18C3", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109653", "mechanisms": ["Interleukin-1 alpha inhibitor"], "genes": ["IL1A"], "type": "Antibody", "diseases": ["ACNE", "PYODERMA", "PSORIASIS", "CANCER", "TYPE II DIABETES MELLITUS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "AMG-108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109458", "mechanisms": ["Interleukin-1 receptor antagonist"], "genes": ["IL1R1"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "OSTEOARTHRITIS", "DIABETES MELLITUS"]}], "heat": 0.30733619753135, "nodes": [{"assoc": 0.222672234356, "id": "ENSG00000115008", "label": "IL1A"}, {"assoc": 0.56, "id": "ENSG00000115590", "label": "IL1R2"}, {"assoc": 0.3960695, "id": "ENSG00000115594", "label": "IL1R1"}, {"assoc": 0.0506030557694, "id": "ENSG00000136697", "label": "IL1F10"}], "size": 4}, {"diseases": ["LEUKEMIA", "MELANOMA", "SICKLE CELL ANEMIA", "CENTRAL NERVOUS SYSTEM CANCER", "ESSENTIAL THROMBOCYTHEMIA", "MULTIPLE SCLEROSIS", "POLYCYTHEMIA VERA", "BETA-THALASSEMIA INTERMEDIA", "MYELODYSPLASTIC SYNDROME", "MENINGIOMA", "FIBROMATOSIS", "NEOPLASM", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "BLADDER CARCINOMA", "BREAST CARCINOMA", "MESOTHELIOMA", "OVARIAN CARCINOMA", "SARCOMA", "ACUTE MYELOID LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "NEOPLASM OF MATURE B-CELLS", "MULTIPLE MYELOMA", "HISTIOCYTOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "CHRONIC MYELOMONOCYTIC LEUKEMIA", "LYMPHOMA", "APLASTIC ANEMIA", "LYMPHOID LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "CUTANEOUS MELANOMA", "CYSTIC FIBROSIS", "CANCER"], "links": [{"source": "ENSG00000048392", "type": "directed", "target": "ENSG00000167325"}, {"source": "ENSG00000048392", "type": "directed", "target": "ENSG00000171848", "reverse": "rev-directed"}, {"source": "ENSG00000167325", "target": "ENSG00000171848", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "ESSENTIAL THROMBOCYTHEMIA", "stage": 3}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 3}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "BETA-THALASSEMIA INTERMEDIA", "stage": 2}, {"efo_term": "MENINGIOMA", "stage": 2}, {"efo_term": "FIBROMATOSIS", "stage": 2}], "max_phase": 4, "name": "HYDROXYUREA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MELANOMA", "SICKLE CELL ANEMIA", "CENTRAL NERVOUS SYSTEM CANCER", "ESSENTIAL THROMBOCYTHEMIA", "MULTIPLE SCLEROSIS", "POLYCYTHEMIA VERA", "BETA-THALASSEMIA INTERMEDIA", "MYELODYSPLASTIC SYNDROME", "MENINGIOMA", "FIBROMATOSIS", "NEOPLASM", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "HISTIOCYTOSIS", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC MYELOMONOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "CLOFARABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MYELODYSPLASTIC SYNDROME", "ACUTE MYELOID LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "NEOPLASM", "NEOPLASM OF MATURE B-CELLS", "MULTIPLE MYELOMA", "HISTIOCYTOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "CHRONIC MYELOMONOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "OVARIAN CARCINOMA", "stage": 4}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GEMCITABINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1637", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["LUNG CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "BLADDER CARCINOMA", "BREAST CARCINOMA", "LEUKEMIA", "MESOTHELIOMA", "OVARIAN CARCINOMA", "SARCOMA"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "LYMPHOID LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "SARCOMA", "stage": 1}, {"efo_term": "APLASTIC ANEMIA", "stage": 1}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 1}], "max_phase": 4, "name": "FLUDARABINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096882", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA", "ACUTE MYELOID LEUKEMIA", "NEOPLASM", "SARCOMA", "SICKLE CELL ANEMIA", "APLASTIC ANEMIA", "LYMPHOID LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 4, "name": "GALLIUM NITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200983", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "TEZACITABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105467", "mechanisms": ["Ribonucleoside-diphosphate reductase RR1 inhibitor"], "genes": ["RRM2B", "RRM1", "RRM2"], "type": "Small molecule", "diseases": ["CANCER"]}], "heat": 0.20058852304666666, "nodes": [{"assoc": 0.2, "id": "ENSG00000048392", "label": "RRM2B"}, {"assoc": 0.2, "id": "ENSG00000167325", "label": "RRM1"}, {"assoc": 0.20176556914, "id": "ENSG00000171848", "label": "RRM2"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000112486", "type": "directed", "target": "ENSG00000115009", "reverse": "rev-stimulatory"}, {"source": "ENSG00000112486", "target": "ENSG00000164825"}], "drugs": [], "heat": 0.22003470734533334, "nodes": [{"assoc": 0.240543487623, "id": "ENSG00000112486", "label": "CCR6"}, {"assoc": 0.387385634413, "id": "ENSG00000115009", "label": "CCL20"}, {"assoc": 0.032175, "id": "ENSG00000164825", "label": "DEFB1"}], "size": 3}, {"diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"], "links": [{"source": "ENSG00000116288", "type": "stimulatory", "target": "ENSG00000163349"}, {"source": "ENSG00000116288", "target": "ENSG00000189043"}], "drugs": [{"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}], "max_phase": 4, "name": "METFORMIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1703", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFA4"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"]}, {"indications": [], "max_phase": 1, "name": "NV-128", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545135", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ME-344", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545320", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFA4"], "type": "Small molecule", "diseases": []}], "heat": 0.5272313748, "nodes": [{"assoc": 0.5653161579, "id": "ENSG00000116288", "label": "PARK7"}, {"assoc": 0.3163779665, "id": "ENSG00000163349", "label": "HIPK1"}, {"assoc": 0.7, "id": "ENSG00000189043", "label": "NDUFA4"}], "size": 3}, {"diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA", "DIABETIC FOOT", "COCAINE DEPENDENCE", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "NARCOLEPSY", "METAMPHETAMINE DEPENDENCE", "STROKE", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "BIPOLAR DISORDER", "CANCER", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "INJURY", "FATIGUE", "ALZHEIMERS DISEASE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "NARCOLEPSY WITH CATAPLEXY", "ORTHOSTATIC HYPOTENSION", "TINNITUS", "SLEEP APNEA", "EWING SARCOMA", "OVARIAN CARCINOMA", "LUNG CARCINOMA", "MOOD DISORDER", "ESOPHAGEAL CARCINOMA", "HYPERSOMNIA", "INSOMNIA", "OBSTRUCTIVE SLEEP APNEA", "NOCTURIA", "OBESITY", "PSYCHOSIS", "AUTISM", "DIABETES MELLITUS", "FISH-EYE DISEASE", "NAUSEA AND VOMITING", "ALCOHOL DEPENDENCE", "MENTAL OR BEHAVIOURAL DISORDER", "TOURETTE SYNDROME", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSORIASIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "POST OPERATIVE NAUSEA AND VOMITING", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "BREAST CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "CONDUCT DISORDER", "NEONATAL ABSTINENCE SYNDROME", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "LYMPHOID NEOPLASM", "FIBROMYALGIA", "TYPE II DIABETES MELLITUS", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY"], "links": [{"source": "ENSG00000128271", "target": "ENSG00000149295"}, {"source": "ENSG00000142319", "target": "ENSG00000149295", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "DEMENTIA", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "FATIGUE", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 0}, {"efo_term": "PARKINSON'S DISEASE", "stage": 0}], "max_phase": 4, "name": "METHYLPHENIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "BIPOLAR DISORDER", "CANCER", "METAMPHETAMINE DEPENDENCE", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "SICKLE CELL ANEMIA", "INJURY", "PARKINSON'S DISEASE", "FATIGUE", "ALZHEIMERS DISEASE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FATIGUE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "EWING SARCOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 1}, {"efo_term": "SLEEP APNEA", "stage": 1}, {"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 0}], "max_phase": 4, "name": "MODAFINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "FATIGUE", "NARCOLEPSY WITH CATAPLEXY", "ORTHOSTATIC HYPOTENSION", "TINNITUS", "POST-TRAUMATIC STRESS DISORDER", "SLEEP APNEA", "EWING SARCOMA", "STROKE", "ALZHEIMERS DISEASE", "OVARIAN CARCINOMA"]}, {"indications": [{"efo_term": "NARCOLEPSY WITH CATAPLEXY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "HYPERSOMNIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "FATIGUE", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "NOCTURIA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}], "max_phase": 4, "name": "ARMODAFINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201192", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ESOPHAGEAL CARCINOMA", "HYPERSOMNIA", "INSOMNIA", "SCHIZOPHRENIA", "NARCOLEPSY WITH CATAPLEXY", "NON-SMALL CELL LUNG CARCINOMA", "UNIPOLAR DEPRESSION", "NEOPLASM", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "INJURY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "OBSTRUCTIVE SLEEP APNEA", "FATIGUE", "STROKE", "NOCTURIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "OVARIAN HYPERSTIMULATION SYNDROME", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "CABERGOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087", "mechanisms": ["Dopamine D2 receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "COCAINE DEPENDENCE", "BREAST CARCINOMA", "OBESITY", "ENDOMETRIOSIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "DEXTROAMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "STROKE", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "INFERTILITY", "stage": 4}, {"efo_term": "HYPERPROLACTINEMIA", "stage": 4}, {"efo_term": "HYPOGONADISM", "stage": 4}, {"efo_term": "GROWTH HORMONE EXCESS", "stage": 4}, {"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "BROMOCRIPTINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200503", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "MOOD DISORDER", "stage": 1}], "max_phase": 4, "name": "BUPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1698", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION", "LUNG CARCINOMA", "MOOD DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}], "max_phase": 4, "name": "LISDEXAMFETAMINE DIMESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "EATING DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "NAUSEA AND VOMITING", "stage": 2}], "max_phase": 4, "name": "PROCHLORPERAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "NAUSEA AND VOMITING", "PSYCHOSIS", "PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 3, "name": "DASOTRALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301595", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "EATING DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "ROTIGOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "AMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "AMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "METHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "CANCER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SACCHARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200992", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544971", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 4, "name": "MAZINDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["OBESITY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 3, "name": "BIFEPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218166", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSORIASIS", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE ENANTHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "PSORIASIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "CARIPRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}], "max_phase": 4, "name": "PRAMIPEXOLE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542257", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "DEXMETHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL904", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "BUPROPION HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201735", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}], "max_phase": 4, "name": "SIBUTRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200765", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "METHAMPHETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["METAMPHETAMINE DEPENDENCE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LIAFENSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364614", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "PERPHENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "TRIFLUPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 3}], "max_phase": 3, "name": "PRIDOPIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596802", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 3, "name": "PARDOPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103832", "mechanisms": ["Dopamine receptors; D2 & D3 partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "APOMORPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1616", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "LEVOMEPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1764", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "ROPINIROLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200411", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIETHYLPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ASPARTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200377", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200387", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENMETRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXTROAMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200782", "mechanisms": ["Dopamine transporter releasing agent"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENDIMETRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1898523", "mechanisms": ["Dopamine transporter inhibitor"], "genes": ["SLC6A3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200587", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZQUINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200707", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLUPHENAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200792", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200856", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201074", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE EDISYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201154", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "APLINDORE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104864", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SARIZOTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146110", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETOPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2360079", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Ordopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545010", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Seridopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545388", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PERGOLIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}], "heat": 0.4583333333333333, "nodes": [{"assoc": 0.125, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 1.0, "id": "ENSG00000142319", "label": "SLC6A3"}, {"assoc": 0.25, "id": "ENSG00000149295", "label": "DRD2"}], "size": 3}, {"diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "IMMUNE SYSTEM DISEASE", "MULTIPLE MYELOMA", "MYELODYSPLASTIC SYNDROME", "TYPE I DIABETES MELLITUS", "GIANT LYMPH NODE HYPERPLASIA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "ASTHMA", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE", "SYSTEMIC LUPUS ERYTHEMATOSUS", "CHRONIC CHILDHOOD ARTHRITIS", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UVEITIS", "GRAVES OPHTHALMOPATHY", "NEUROMYELITIS OPTICA", "NEOPLASM"], "links": [{"source": "ENSG00000136244", "type": "stimulatory", "target": "ENSG00000160712", "reverse": "rev-directed"}, {"source": "ENSG00000160712", "target": "ENSG00000164307"}], "drugs": [{"indications": [{"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 3}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "FIBROUS DYSPLASIA OF BONE", "stage": 2}, {"efo_term": "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "TOCILIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237022", "mechanisms": ["Interleukin-6 receptor alpha subunit inhibitor"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["CHRONIC CHILDHOOD ARTHRITIS", "RHEUMATOID ARTHRITIS", "SCHIZOPHRENIA", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "IMMUNE SYSTEM DISEASE", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION", "UVEITIS", "TYPE I DIABETES MELLITUS", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "GIANT LYMPH NODE HYPERPLASIA", "stage": 4}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 0}], "max_phase": 4, "name": "SILTUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743070", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "MULTIPLE MYELOMA", "MYELODYSPLASTIC SYNDROME", "TYPE I DIABETES MELLITUS", "GIANT LYMPH NODE HYPERPLASIA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 2, "name": "CLAZAKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108589", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}], "max_phase": 3, "name": "SARILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108730", "mechanisms": ["Interleukin-6 receptor alpha subunit antagonist"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC CHILDHOOD ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 3, "name": "SIRUKUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743071", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "UNIPOLAR DEPRESSION", "ASTHMA"]}, {"indications": [{"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "TOSEDOSTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103847", "mechanisms": ["Aminopeptidases inhibitor"], "genes": ["ERAP1"], "type": "Small molecule", "diseases": ["NEOPLASM", "MYELODYSPLASTIC SYNDROME", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 3, "name": "OLOKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743050", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 2, "name": "PF-04236921", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109613", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["SYSTEMIC LUPUS ERYTHEMATOSUS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "NEUROMYELITIS OPTICA", "stage": 3}], "max_phase": 0, "name": "SA237", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833307", "mechanisms": ["IL6Ralpha/GP130 antagonist"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["NEUROMYELITIS OPTICA"]}, {"indications": [], "max_phase": 2, "name": "ELSILIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108591", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": []}], "heat": 0.6002574092026667, "nodes": [{"assoc": 0.144727227608, "id": "ENSG00000136244", "label": "IL6"}, {"assoc": 0.656045, "id": "ENSG00000160712", "label": "IL6R"}, {"assoc": 1.0, "id": "ENSG00000164307", "label": "ERAP1"}], "size": 3}], "auto_delta": "0.00477608"}